×

Lim SY, Park HW, Chung WY, Kim SY, Kim KS, Bae JW, Youn TJ; PROMETHEUS Study Investigators. The efficacy and safety of PRO-kinetic metal alloy stent in hospitalized patients with

acute ST-elevation myocardial infarction (The PROMETHEUS Study). J Invasive Cardiol. 2012;24(6):270-3.



Koh JS, Park JH, Shin DH, Youn TJ, Oh IY, Yoon CH, Suh JW, Cho YS, Cho GY, Chae IH, Choi DJ. Risk factors and effects on long-term outcomes of cardiac troponin I elevation after

drug-eluting stent implantation in patients with stable coronary artery disease. Am J Cardiol. 2012;109(4):461-5.



Park K, Youn TJ, Park KW, Na SH, Lee HY, Kang HJ, Chung WY, Koo BK, Chae IH, Choi DJ, Kim HS, Oh BH, Park YB. Physiologic evaluation of myocardial bridging: a new analysis for an

old disease. Can J Cardiol. 2011;27(5):596-600.



Shin DH, Choi DJ, Youn TJ, Yoon CH, Suh JW, Kim KI, Cho YS, Cho GY, Chae IH, Kim CH. Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal

insufficiency undergoing coronary angiography. Am J Cardiol. 2011;108(2):189-94.



Park SJ, Youn TJ, Oh IY, Kim KH, Kim JH, Yang HM, Chun E, Cho GY, Choi DJ. Images in cardiology. Atrial fibrillation as a potential risk for ST-segment elevation myocardial infarction. J

Am Coll Cardiol. 2010;55(23):e141.



Park SJ, Kim KH, Oh IY, Shin DH, Park KI, Seo MK, Chung JW, Park KW, Lee HY, Kang HJ, Koo BK, Youn TJ, Kim HS. Comparison of plain balloon and cutting balloon angioplasty for the

treatment of restenosis with drug-eluting stents vs bare metal stents. Circ J. 2010;74(9):1837-45.



Shin DH, Chae IH, Youn TJ, Cho SI, Kwon DA, Suh JW, Chang HJ, Cho YS, Chung WY, Choi YJ, Gwon HC, Han KR, Choi DJ. Reasonable duration of Clopidogrel use after drug-eluting

stent implantation in Korean patients. Am J Cardiol 2009; 104(12): 1668-73.



Jo SH, Youn TJ, Koo BK, Park JS, Kang HJ, Cho YS, Chung WY, Joo GW, Chae IH, Choi DJ, Oh BH, Lee MM, Park YB, Kim HS. Renal toxicity evaluation and comparison between

visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. J Am Coll Cardiol.

2006; 48(5): 924-30.



Piao H, Youn TJ, Kwon JS, Kim YH, Bae JW, Bora-Sohn, Kim DW, Cho MC, Lee MM, Park YB. Effects of bone marrow derived mesenchymal stem cells transplantation in acutely infarcting

myocardium. Eur J Heart Fail. 2005; 7(5): 730-8.



Youn TJ, Piao H, Kwon JS, Choi SY, Kim HS, Park DG, Kim DW, Kim YG, Cho MC. Effects of the calcineurin dependent signaling pathway inhibition by cyclosporin A on early and late

cardiac remodeling following myocardial infarction. Eur J Heart Fail. 2002; 4(6): 713-8.



Youn TJ, Kim HS, Kang HJ, Kim DW, Cho MC, Kim CH, Oh BH, Lee MM, Park YB. Inhibition of nitric oxide synthesis increases apoptotic cardiomyocyte death and myocardial angiotensin-

converting enzyme gene expression in ischemia/reperfusion-injured myocardium of rats. Heart Vessels. 2001; 16(1): 12-9.



Youn TJ, Kim HS, Oh BH. Ventricular remodeling and transforming growth factor-beta 1 mRNA expression after nontransmural myocardial infarction in rats: effects of angiotensin

converting enzyme inhibition and angiotensin II type 1 receptor blockade. Basic Res Cardiol. 1999; 94(4): 246-53.